GI
NVAX icon

GAMMA Investing’s Novavax NVAX Stock Holding History

GAMMA Investing’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.2K Buy
1,223
+271
+28% +$2.43K ﹤0.01% 3186
2026
Q2 		$8.97K Sell
952
-160
-14% -$1.43K ﹤0.01% 3266
2026
Q1 		$9.05K Buy
1,112
+503
+83% +$4.56K ﹤0.01% 3118
2025
Q4 		$4.09K Sell
609
-1,050
-63% -$7.92K ﹤0.01% 3365
2025
Q3 		$14.4K Buy
1,659
+625
+60% +$4.86K ﹤0.01% 2691
2025
Q2 		$6.51K Sell
1,034
-813
-44% -$5.38K ﹤0.01% 3017
2025
Q1 		$11.8K Buy
1,847
+1,348
+270% +$11.1K ﹤0.01% 2669
2024
Q4 		$4.01K Buy
499
+259
+108% +$2.5K ﹤0.01% 3002
2024
Q3 		$3.03K Buy
240
+194
+422% +$2.5K ﹤0.01% 2930
2024
Q2 		$582 Sell
46
-54
-54% -$543 ﹤0.01% 3181
2024
Q1 		$478 Buy
+100
New +$464 ﹤0.01% 3112

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's NVAX Position: Q3 2026 in Review

GAMMA Investing increased its Novavax (NVAX) stake by 28% in Q3 2026, buying an estimated $2.43K and bringing the position to 1,223 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3186.

GAMMA Investing first reported a position in NVAX in Q1 2024 and has held it in 11 quarters since. The position peaked at $14.4K in Q3 2025. 5 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • GAMMA Investing held 1,223 shares of Novavax worth $13.2K as of Q3 2026.
  • GAMMA Investing bought 271 Novavax shares in Q3 2026, an estimated $2.43K.
  • Novavax made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3186 holding.
  • GAMMA Investing first reported a position in Novavax in Q1 2024 and has held it in 11 quarters since.
  • GAMMA Investing's Novavax position peaked at $14.4K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.